Clinical management of patients with insomnia. The role of zopiclone.
Clinical management of patients with insomnia. The role of zopiclone.
复制标题
失眠患者的临床治疗。
DOI：
--
复制
发表时间：
1996
期刊：
影响因子：
--
通讯作者：
A. Rodenbeck
中科院分区：
文献类型：
--
作者：
G. Hajak;A. Rodenbeck
失眠，尤其是慢性失眠，与白天的健康和表现紊乱有关，导致受影响者的生活质量较差。佐匹克隆已被证明是一种药物，在失眠的对症治疗中，有利于平衡睡眠诱导和维持，以及改善白天的健康（功效），不良反应（安全性）的可能性低。佐匹克隆治疗慢性失眠症需要多维度的方法，包括正确诊断可能的潜在原因，并结合因果治疗、一般睡眠卫生措施、心理治疗的基本要素和辅助药物。建议使用非苯二氮卓类催眠药物佐匹克隆治疗应符合催眠药物使用指南，该指南适用于所有苯二氮卓类受体激动剂。
Insomnia, especially when chronic, is associated with disturbances in daytime well-being and performance, resulting in a poor quality of life for those affected. Zopiclone has been proven as a drug that favourably balances sleep induction and maintenance as well as an improvement in daytime well-being (efficacy) with a low potential for adverse effects (safety) in the symptomatic treatment of insomnia. Management of chronic insomnia with zopiclone needs a multidimensional approach involving the proper diagnosis of possible underlying causes, and combined use of causal treatment, general sleep hygiene measures, basic elements of psychological treatment and adjunctive medication. It is recommended that therapy with the nonbenzodiazepine hypnotic zopiclone should conform to the guidelines for the use of hypnotics, which are valid for all benzodiazepine receptor agonists.